PRL-8-53 – Solution, 600mg (25mg/mL)
PRL-8-53 – Solution, 600mg (25mg/mL)
Couldn't load pickup availability
PRL-8-53
PRL-8-53 is a nootropic research chemical derived from benzoic acid and phenylmethylamine that has been shown to act as a hypermnesic drug in humans; it was first synthesized by medical chemistry professor Nikolaus Hansl at Creighton University in the 1970s as part of his work on amino ethyl meta benzoic acid esters. Hypermnesic drugs are capable of enhancing cognition, memory, and treatment of certain medical conditions. PRL is being widely touted as the drug that aids in learning and memory retention.
Concentration
25mg/ml.
DISCLAIMER
This material is sold for use in laboratory research only. Terms of sale apply. Not for human consumption, nor for medical, veterinary or household use. Please familiarize yourself with our DISCLAIMER before ordering.
Data Sheet
PRL-8-53 – Powder
| Application | Hypermnesic, Unknown MOA |
| CAS | 51352-88-6 |
| Molar Mass | 319.83 g/mol |
| Chemical Formula | C18H22ClNO2 |
| IUPAC Name | benzyl-[2-(3-methoxycarbonylphenyl)ethyl]-methylazanium;chloride |
| Synonyms | Methyl 3-(2-(benzylmethylamino)ethyl)benzoate hydrochloride, 3-(2-benzylmethylaminoethyl) benzoic acid methyl ester hydrochloride, 3-(2-(Methyl(phenylmethyl)amino)ethyl)benzoic acid methyl ester hydrochloride, AC1L22UR, CTK4J4081, LS-36115 |
| Storage | Store at room temperature, tightly sealed, away from heat, light and moisture. |
| Solubility | Soluble in Deionized Water, Ethanol. |
| Organoleptic Profile | White powder |
| Physical Form | Solution in Propylene Glycol |
| Specification | ≥98% |
| Terms | This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering. |
